Page last updated: 2024-10-30

lomustine and Dermatitis Medicamentosa

lomustine has been researched along with Dermatitis Medicamentosa in 2 studies

Research Excerpts

ExcerptRelevanceReference
"We describe 5 cases of chemotherapy-related reticulate hyperpigmentation in patients treated with different chemotherapeutic regimens, in particular paclitaxel or cytarabine."4.91Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature. ( Boulinguez, S; Gadaud, N; Gladieff, L; Guenounou, S; Lamant, L; Masson Regnault, M; Recher, C; Roche, H; Sibaud, V; Tournier, E, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Masson Regnault, M1
Gadaud, N1
Boulinguez, S1
Tournier, E1
Lamant, L1
Gladieff, L1
Roche, H1
Guenounou, S1
Recher, C1
Sibaud, V1
Chahinian, AP1
Mandel, EM1
Holland, JF1
Jaffrey, IS1
Teirstein, AS1

Reviews

1 review available for lomustine and Dermatitis Medicamentosa

ArticleYear
Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature.
    Dermatology (Basel, Switzerland), 2015, Volume: 231, Issue:4

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosp

2015

Other Studies

1 other study available for lomustine and Dermatitis Medicamentosa

ArticleYear
MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer.
    Cancer, 1979, Volume: 43, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell;

1979